论文部分内容阅读
辅酶Q_(10)(Coenzyme Q_(10),又名ubiquione简称CoQ_(10))是一种新的生化药物。在呼吸链中,它是一种可逆的递氢体,可激活细胞代谢和细胞呼吸,具有重要的生理和生化作用。1974年日本已有CoQ_(10)正式商品销售,在临床上用于治疗心脏疾患(如充血性心力衰竭,缺血性心衰等)、高血压、脑血管障碍、各种感染、恶性肿瘤等。1974年起,云南省动物研究所、江苏省泰州市生物制药厂和北京大学制药厂共同协作,研制CoQ_(10),1976年国内开始应
Coenzyme Q_ (10) (Coenzyme Q_ (10), also known as ubiquione referred to as CoQ_ (10)) is a new biochemical drug. In the respiratory chain, it is a reversible hydrogen transporter that activates cellular metabolism and cellular respiration and has important physiological and biochemical effects. In 1974 Japan had CoQ_ (10) official sales of goods in the clinical treatment of heart disease (such as congestive heart failure, ischemic heart failure, etc.), hypertension, cerebrovascular disorders, various infections, malignant tumors . Since 1974, Yunnan Institute of Zoology, Taizhou City, Jiangsu Province Pharmaceutical Factory and Peking University Pharmaceutical Factory work together to develop CoQ_ (10), 1976 domestic should be